Stock Scorecard
Stock Summary for Neogen Corp (NEOG) - $15.99 as of 9/6/2024 4:02:59 PM EST
Total Score
7 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for NEOG
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NEOG
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NEOG
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NEOG
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for NEOG
Financial Details for NEOG
Company Overview |
|
---|---|
Ticker | NEOG |
Company Name | Neogen Corp |
Country | USA |
Description | Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan. |
Sector Name | LIFE SCIENCES |
Industry Name | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
Most Recent Quarter | 5/31/2024 |
Next Earnings Date | 10/8/2024 |
Stock Price History |
|
Last Day Price | 15.99 |
Last Day Price Updated | 9/6/2024 4:02:59 PM EST |
Last Day Volume | 1,679,378 |
Average Daily Volume | 1,691,336 |
52-Week High | 21.88 |
52-Week Low | 11.46 |
Last Price to 52 Week Low | 39.53% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 25.09 |
Sector PE | 80.12 |
5-Year Average PE | 63.65 |
Free Cash Flow Ratio | 20.50 |
Industry Free Cash Flow Ratio | 36.33 |
Sector Free Cash Flow Ratio | 30.42 |
Current Ratio Most Recent Quarter | 3.82 |
Total Cash Per Share | 0.78 |
Book Value Per Share Most Recent Quarter | 14.52 |
Price to Book Ratio | 1.06 |
Industry Price to Book Ratio | 10.82 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 3.62 |
Industry Price to Sales Ratio Twelve Trailing Months | 7.54 |
Sector Price to Sales Ratio Twelve Trailing Months | 6.66 |
Share Statistics |
|
Total Shares Outstanding | 216,694,000 |
Market Capitalization | 3,464,937,060 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 2.19% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -85.60% |
Annual Earnings Growth | -147.34% |
Reported EPS 12 Trailing Months | -0.04 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 0.44 |
Net Income Twelve Trailing Months | 1,566,000 |
Net Income Past Year | -22,870,000 |
Net Income Prior Year | 48,307,000 |
Quarterly Revenue Growth YOY | -2.10% |
5-Year Revenue Growth | 14.97% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 168,447,000 |
Total Cash Past Year | 245,569,000 |
Total Cash Prior Year | 717,629,000 |
Net Cash Position Most Recent Quarter | -719,206,000 |
Net Cash Position Past Year | -1,549,336,000 |
Long Term Debt Past Year | 1,794,905,000 |
Long Term Debt Prior Year | 0 |
Total Debt Most Recent Quarter | 887,653,000 |
Equity to Debt Ratio Past Year | 0.64 |
Equity to Debt Ratio Most Recent Quarter | 0.78 |
Total Stockholder Equity Past Year | 3,134,217,000 |
Total Stockholder Equity Prior Year | 887,374,000 |
Total Stockholder Equity Most Recent Quarter | 3,146,174,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -13,188,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.06 |
Free Cash Flow Past Year | -24,729,000 |
Free Cash Flow Prior Year | 43,609,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.02 |
MACD Signal | 0.07 |
20-Day Bollinger Lower Band | 11.75 |
20-Day Bollinger Middle Band | 15.32 |
20-Day Bollinger Upper Band | 18.90 |
Beta | 1.20 |
RSI | 44.68 |
50-Day SMA | 16.10 |
150-Day SMA | 21.68 |
200-Day SMA | 27.00 |
System |
|
Modified | 9/7/2024 8:28:14 AM EST |